CMAJ • September 11, 2007; 177 (6). doi:10.1503/cmaj.1070055.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Röggla, G.
Right arrow Articles by Kapiotis, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Röggla, G., MD
Right arrow Articles by Kapiotis, S., MD
Related Collections
Right arrow Other endocrinology
Right arrow Drugs: cardiovascular system


Letters

Treating hypertriglyceridemia

Georg Röggla, MD, Michael Fasan, MD and Stylianos Kapiotis, MD

Department of Internal Medicine, General Hospital of Neunkirchen, Neunkirchen, Austria

In their review of hypertriglyceridemia, George Yuan and colleagues advocate "hemodynamic stabilization, cessation of all oral intake, placement of a nasogastric tube and control of metabolic disturbances" to treat triglyceride-related acute pancreatitis.1 The authors are skeptical about the use of plasmapheresis because it provides only a transient benefit.


Figure 121
View larger version (106K):
[in this window]
[in a new window]

 
Figure 1: Serum of a patient with triglyceride-related acute pancreatitis. Left: Lipemic serum before treatment with insulin and heparin. Right: Clear serum after 5 days of therapy.

 
We use a different treatment method (heparin and insulin infusions to stimulate lipoprotein lipase activity and therefore reduce serum triglyceride levels2)as the first-line therapy in our hospital, as described in the following case. A 29-year-old man with an uneventful medical history was admitted to hospital because of severe abdominal pain with a clinical diagnosis of acute pancreatitis. The fasting triglyceride level was nearly 8000 mg/dL at admission. In addition to standard therapy for pancreatitis, an insulin infusion was started at 4 IU/h with glucose substitution as necessary. Low-molecular-weight heparin was also administered. Within 5 days the patient was asymptomatic and his triglyceride level had decreased to 450 mg/dL. His lipemic serum had a milky appearance at admission and a nearly normal clear appearance on day 5 (Figure 1). Case series and case reports describing the treatment of pancreatitis with heparin and insulin have been published,35 but the efficacy of this treatment method has not yet been well established, presumably because of the lack of controlled trials.

Footnotes

Competing interests: None declared.


REFERENCES

  1. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007;176:1113-20.[Abstract/Free Full Text]
  2. Alagozlu H, Cindoruk M, Karakan T, et al. Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis. Dig Dis Sci 2006;51:931-3.[CrossRef][Medline]
  3. Kyriakidis AV, Raitsiou B, Sakagianni A, et al. Management of acute severe hyperlipidemic pancreatitis. Digestion 2006;73:259-64.[CrossRef][Medline]
  4. Tamez-Perez HE, Saenz-Gallegos R, Hernandez-Rodriguez K, et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev Med Inst Mex Seguro Soc 2006;44:235-7.[Medline]
  5. Henzen C, Rock M, Schnieper C, et al. Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis. Schweiz Med Wochenschr 1999;129:1242-8.[Medline]



This article has been cited by other articles:


Home page
Arch Intern MedHome page
R. P. Cole
Heparin Treatment for Severe Hypertriglyceridemia in Diabetic Ketoacidosis
Arch Intern Med, August 10, 2009; 169(15): 1439 - 1441.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Röggla, G.
Right arrow Articles by Kapiotis, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Röggla, G., MD
Right arrow Articles by Kapiotis, S., MD
Related Collections
Right arrow Other endocrinology
Right arrow Drugs: cardiovascular system